Insight

Kimryn Rathmell: The impact of photon therapy among Childhood Cancer survivors and the risk of second cancer

Collage photo of Kimryn Rathmell and Cari Kitahara

Oct 5, 2024, 17:29

Kimryn Rathmell: The impact of photon therapy among Childhood Cancer survivors and the risk of second cancer

Kimryn Rathmell shared a post on X by the NIH Intramural Research Program, adding:

“Nice article on the work of NCI investigator Dr. Cari Kitahara. She studies the impact of photon and proton therapies among Childhood Cancer survivors and their risk of second cancer—an interdisciplinary and collaborative effort.”

Quoting NIH Intramural Research Program’s post:

“NIH IRP researchers are exploring the benefits and drawbacks of different radiation therapies used to treat cancer. Results from the study could help inform doctors’ treatment decisions and follow-up care for childhood cancer survivors.”

Read further.
Sources: Kimryn Rathmell/X and NIH Intramural Research Program/X

More posts featuring Kimryn Rathmell.

Dr. Kimryn Rathmell serves as the director of the National Cancer Institute. She is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers.

She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.

Dr. Cari Kitahara, an epidemiologist and senior investigator in the Radiation Epidemiology Branch, specializes in medical radiation exposure and cancer risks, particularly thyroid cancer and glioma. She serves on the Scientific Program Committees of the American Thyroid Association and ISoRED, and is also an editor of Thyroid.